Skip to main content

Table 1 Demographic and clinical variables according to King’s college stages

From: Health-related quality of life in amyotrophic lateral sclerosis using EQ-5D-5L

 

Total

(n = 547)

Stage 1

(n = 224)

Stage 2

(n = 193)

Stage 3

(n = 86)

Stage 4

(n = 44)

P value

Age, years (M (SD))

54.7 (11.4)

54.0 (11.0)

55.1 (11.8)

55.1 (12.7)

55.5 (9.5)

0.796

Male (n, (%))

347 (63.4)

153 (68.3)

114 (59.1)

52 (60.5)

28 (63.6)

0.240

Education, years (M (SD))

9.4 (3.6)

9.7 (3.8)

9.1 (3.4)

8.8 (3.4)

9.5 (3.7)

0.081

Age at onset, years (M (SD))

53.4 (11.4)

52.8 (11.1)

53.8 (11.7)

53.9 (12.6)

53.8 (9.5)

0.865

Disease duration, months (M (SD))

15.5 (14.4)

15.1 (14.3)

15.2 (14.3)

14.5 (13.2)

20.7 (16.5)

0.049

Diagnostic delay, months (M (SD))

14.6 (14.0)

14.3 (13.6)

14.3 (14.1)

13.6 (13.1)

20.1 (16.6)

0.034

Onset region (B, UL, LL)

68, 273, 206

30, 109, 85

22, 96, 75

10, 47, 29

6, 21,17

0.967

ALSFRS-R score, (M (SD)

41.4 (4.4)

44.4 (2.4)

40.8 (3.4)

37.6 (4.2)

36.4 (5.1)

< 0.001*

BMI, M (SD)

22.6 (3.1)

22.8 (3.1)

22.5 (3.2)

22.5 (3.1)

22.5 (3.2)

0.806

  1. ALSFRS-R, Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised; B, bulbar onset; UL, upper limb; LL, lower limb; BMI, body mass index; M, mean; SD, standard deviation
  2. *Significant difference. P values were Bonferroni-adjusted